Compare Baxter International Inc (BAX) vs Coursera Inc (COUR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Coursera Inc — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while Coursera Inc trades at $5.72 (market cap $1.64B). The key difference: Baxter International Inc is far larger — about 6.9× Coursera Inc's market cap, and Baxter International Inc pays a 0.92% dividend while Coursera Inc pays none. Which is the better fit depends on your goals.
| BAX | COUR | |
|---|---|---|
Market Cap | $11.26B | $1.64B |
Sector | Health | Consumer Staples |
52-Week High | $29.22 | $12.70 |
52-Week Low | $15.80 | $5.09 |
Enterprise Value | $18.93B | $890.21M |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
Coursera (COUR) trades at $5.67, down 0.7% on the day, with technical indicators showing a bearish trend. The company reported Q1 2026 earnings of $0.07 per share, missing estimates of $0.09, but revenue growth remains positive, reaching $757.5 million in 2025. Recent news highlights the completion of the Udemy merger and a $500 million share repurchase program, while analyst sentiment is mixed with a consensus price target of $8.00.
The outlook for COUR is cautiously optimistic, driven by potential synergies from the Udemy merger and steady revenue growth, though profitability challenges and competitive pressures pose risks. With a 52.94% buy rating from analysts and a 38.5% upside to the consensus target, the stock offers growth potential, but investors should monitor execution on cost management and integration success.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →
